• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Obstetrics

Greatest reduction in pregnancy occurs with any contraception

byDenise PongandLeah Hawkins Bressler, MD, MPH
April 3, 2016
in Obstetrics
Reading Time: 2 mins read
Greatest reduction in pregnancy occurs with any contraception
Share on FacebookShare on Twitter

1. Adoption of any contraceptive method among non-users was associated with a greater reduction in unintended pregnancy rate than adoption of LARC among women using a less effective method.

2. Among current contraceptive users, adoption of long-acting reversible contraception (LARC) was associated with a decrease in unintended pregnancy rate.

Evidence Rating Level: 2 (Good)

Study Rundown: Unintended pregnancies comprise approximately half of all pregnancies in the United States. Women who are unmarried, less than 15 years old, and of lower socioeconomic status are more likely to experience unplanned pregnancy. While many unplanned pregnancies are also undesired and are terminated, continued pregnancies are associated with significant infant and maternal morbidity. As such, significant efforts have been made to increase the use of LARC, such as intrauterine devices (IUDs) and implants, to decrease the rate of undesired pregnancies. Previous research demonstrated that risk of pregnancy in women using a LARC method is significantly lower than in women using less effective methods, such as oral contraception (OCP) and condoms. However, the population-level effects of choices regarding contraception have been less well studied. In the present work, authors performed simulations to evaluate the impact of adoption of any contraceptive method among non-users and the impact of choice of method among current users. They found that adoption of any method of contraception among non-users was associated with a greater reduction in the incidence of unintended pregnancy than adoption of LARC among users of less effective methods.

Strengths of the study included model parameters based on national data and real-world behaviors. The study was limited by simulated model variables and lack of data regarding women’s pregnancy intentions. Population-based prospective studies are needed to evaluate the accuracy of the results of these simulations and better tailor family planning interventions.

Click to read the study in Contraception

RELATED REPORTS

Use of semaglutide for weight control among women of reproductive age is more common in those using hormonal contraception

The Scan by 2 Minute Medicine®: Patient Zero: Immunotherapy for Brain Tumors?, Over-the-Counter Birth Control, Florida Supreme Court Deals a Devastating Blow to Abortion Access, Schwarzenegger’s Post-Pacemaker Update on Instagram

Piroxicam may augment the clinical efficacy of levonorgestrel in emergency contraception

Relevant Reading: Non-use of contraception among women at risk of unintended pregnancy in the United States

In-Depth [population-based study]: This population-based simulation evaluated the population-level effects of contraceptive adoption and method among 50,000 unmarried individuals. Model parameters included demographics, sexual activity, contraceptive behavior and fecundity. Contraceptive method was categorized into non-use; LARC, which included IUD, implants, and injectables; and OCP, patch or vaginal ring. The primary outcome of interest was probability of pregnancy within 12 sexually active months.

Models assuming adoption of a contraceptive method among 5% of those not currently using contraception predicted a 6.3%, 10.3%, and 12.7% decrease in pregnancy rate among those adopting condom; pill, patch or vaginal ring, and LARC use respectively. The rate reduction when 5% of condom users and pill, patch or ring users switched to LARC was only 3.6% and 1.7% respectively.

Image: CC/Wiki/BruceBlaus

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: contraceptionlong-acting reversible contraception (LARC)unintended pregnancy
Previous Post

Longer duration of antibiotic therapy does not reduce persistent symptoms in Lyme disease

Next Post

Carbon nanotube delivery of siRNAs could prevent kidney injury [PreClinical]

RelatedReports

Sleep duration inversely related to childhood type 2 diabetes risk makers
Endocrinology

Use of semaglutide for weight control among women of reproductive age is more common in those using hormonal contraception

July 30, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Patient Zero: Immunotherapy for Brain Tumors?, Over-the-Counter Birth Control, Florida Supreme Court Deals a Devastating Blow to Abortion Access, Schwarzenegger’s Post-Pacemaker Update on Instagram

April 16, 2024
1 in 5 US women report delayed contraceptive initiation after sexual debut
Emergency

Piroxicam may augment the clinical efficacy of levonorgestrel in emergency contraception

September 27, 2023
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Obstetrics

Unintended pregnancy significantly associated with adverse maternal and infant health outcomes compared to intended pregnancy

November 8, 2022
Next Post
Being overweight and obese associated with increased incidence of chronic kidney disease

Carbon nanotube delivery of siRNAs could prevent kidney injury [PreClinical]

PCSK9 antibodies safe and effective in treating dyslipidemia

Estradiol may be anti-atherosclerotic in early postmenopausal women: the ELITE study

Increasing survival rates for patients with acute liver failure

Increasing survival rates for patients with acute liver failure

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deficits in executive function are not universal among patients with alcohol use disorder
  • Choice of bicarbonate-buffered solution versus compound sodium lactate as the intraoperative crystalloid solution during abdominal surgery remains unclear
  • Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.